Loading clinical trials...

14-Day Cumulative Irritation Patch Test in Subjects With Normal Skin - Chameleon | Clinical Trials | Clareo Health

COMPLETEDNANCT02737618

14-Day Cumulative Irritation Patch Test in Subjects With Normal Skin - Chameleon

to determine the ability of the test article to cause irritation to the skin of humans under controlled patch test conditions

Lead sponsor: Church & Dwight Company, Inc.•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDNA

Evaluation of Experimental Heat Patch

NCT01841788 · Effects of Heat, Tolerability, and more

COMPLETEDNA

Evaluation of Experimental and Commercial Air-Activated, Adhesive Backed Heat Patches

NCT01841801 · Effects of Heat, Tolerability, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 1, 2017Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment35

Start dateFeb 2016

Last updatedSep 1, 2017

Condition

Dermal Irritation

Locations shown

TKL Research Inc

Fair Lawn, New Jersey

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 1, 2017Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions